Related Experiment Video
Updated: Feb 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Lobohedleolide suppresses hepatitis C virus replication via JNK/c-Jun-C/EBP-mediated down-regulation of
Chun-Kuang Lin1,2, Chin-Kai Tseng3,4, Chih-Chuang Liaw1,5
1Doctoral Degree Program in Marine Biotechnology, College of Marine Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Abstract:
Hepatitis C virus (HCV) chronically infects 2-3% people of the global population, which leads to liver cirrhosis and hepatocellular carcinoma. Drug resistance remains a serious problem that limits the effectiveness of US Food and Drug Administration (FDA)-approved direct-acting antiviral (DAA) drugs against HCV proteins. The objective of our study was to discover new antivirals from natural products to supplement current therapeutics. We demonstrated that lobohedleolide, isolated from the Formosan soft coral Lobophytum crassum, significantly reduced HCV replication in replicon cells and JFH-1 infection system, with EC50 values of 10 ± 0.56 and 22 ± 0.75 μM, respectively, at non-toxic concentrations. We further observed that the inhibitory effect of lobohedleolide on HCV replication is due to suppression of HCV-induced cyclooxygenase-2 (COX-2) expression. Based on deletion-mutant analysis of the COX-2 promoter, we identified CCAAT/enhancer-binding protein (C/EBP) as a key transcription factor for the down-regulation of COX-2 by lobohedleolide, through which lobohedleolide decreased the phosphorylation of c-Jun NH2-terminal protein kinase and c-Jun to suppress HCV-induced C/EBP expression. The combination treatment of lobohedleolide with clinically used HCV drugs synergistically reduced HCV RNA replication, indicating that lobohedleolide exhibited a high biomedical potential to be used as a supplementary therapeutic agent to control HCV infection.
Insights
A natural compound, lobohedleolide, effectively inhibits Hepatitis C virus (HCV) replication by targeting cyclooxygenase-2 (COX-2) expression. This discovery offers a potential new strategy to combat drug-resistant HCV infections.
Area of Science:
- Marine natural products chemistry
- Virology
- Drug discovery
Background:
- Hepatitis C virus (HCV) infection affects millions globally, leading to severe liver diseases.
- Existing direct-acting antiviral (DAA) drugs face challenges due to drug resistance.
- Novel therapeutic strategies are crucial to overcome limitations of current HCV treatments.
Purpose of the Study:
- To identify and characterize novel antiviral compounds from natural sources.
- To evaluate the efficacy of lobohedleolide, a compound from Lobophytum crassum, against HCV.
- To elucidate the mechanism of action of lobohedleolide in inhibiting HCV replication.
Main Methods:
- Isolation and purification of lobohedleolide from the soft coral Lobophytum crassum.
- Antiviral activity assays using HCV replicon cells and JFH-1 infection systems.
- Analysis of cyclooxygenase-2 (COX-2) expression and its promoter activity.
- Investigation of signaling pathways including c-Jun NH2-terminal protein kinase (JNK) and CCAAT/enhancer-binding protein (C/EBP).
Main Results:
- Lobohedleolide demonstrated significant reduction of HCV replication with low micromolar EC50 values.
- The compound's antiviral effect was attributed to the suppression of HCV-induced COX-2 expression.
- Lobohedleolide down-regulates COX-2 by inhibiting C/EBP expression via reduced JNK and c-Jun phosphorylation.
- Combination therapy with lobohedleolide and existing HCV drugs showed synergistic effects.
Conclusions:
- Lobohedleolide is a potent inhibitor of HCV replication with a novel mechanism of action.
- The compound suppresses viral replication through the down-regulation of COX-2 and C/EBP.
- Lobohedleolide shows significant potential as a supplementary therapeutic agent for managing HCV infection, especially in cases of drug resistance.
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Cell Specific Gene Expression
Regulation of Expression at Multiple Steps
What are Viruses?
Constitutive and Regulated Gene Expression

